Characteristics and natural disease history of persistent idiopathic facial pain, trigeminal neuralgia, and neuropathic facial pain.
International Classification of Headache Disorders, 3rd edition
atypical facial pain
orofacial pain
persistent idiopathic facial pain
treatment
trigeminal neuralgia
Journal
Headache
ISSN: 1526-4610
Titre abrégé: Headache
Pays: United States
ID NLM: 2985091R
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
revised:
05
08
2021
received:
12
04
2021
accepted:
18
08
2021
pubmed:
8
10
2021
medline:
15
2
2022
entrez:
7
10
2021
Statut:
ppublish
Résumé
This study aimed to characterize key features, and to assess the clinical development of common nondental facial pain syndromes such as persistent idiopathic facial pain (PIFP), trigeminal neuralgia (TN), and neuropathic facial pain (NEUROP). This is a longitudinal study in which prospective questionnaire data of patients presenting to a specialized outpatient clinic were collected from 2009 to 2019. A telephone interview was conducted with the same patients in 2020 to assess the natural disease history. n = 411 data sets of patients with chronic facial pain were compiled. Among these were n = 150 patients with PIFP, n = 111 patients with TN, and n = 86 patients with NEUROP. Guideline therapy had not been initiated in 38.7% (58/150; PIFP), 19.8% (22/111; TN), and 33.7% (29/86; NEUROP) patients. Of the patients with PIFP, 99.3% (149/150) had primarily consulted a dentist due to their pain syndrome. The additional telephone interview was completed by 236 out of the 411 patients (57.4%). Dental interventions in healthy teeth had been performed with the intention to treat the pain in many patients (78/94 [83.0%] PIFP; 34/62 [54.8%] TN; 19/43 [44.2%] NEUROP), including dental extractions. 11.3% (7/43) of the patients with TN had never profited from any therapy. In contrast, 29.8% (28/94) of the patients with PIFP had never profited from any therapy. Furthermore, the primary pharmaceutical therapy options suggested by national guidelines were, depending on the substance class, only considered to be effective by 13.8% (13/94; antidepressants) and 14.9% (14/94; anticonvulsants) of the patients with PIFP. Facial pain syndromes pose a considerable disease burden. Although treatment of TN seems to be effective in most patients, patients with PIFP and NEUROP report poor effectiveness even when following guideline therapy suggestions. In addition, unwarranted dental interventions are common in facial pain syndromes.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1441-1451Informations de copyright
© 2021 The Authors. Headache: The Journal of Head and Face Pain published by Wiley Periodicals LLC on behalf of American Headache Society.
Références
Zakrzewska JM, Wu J, Mon-Williams M, Phillips N, Pavitt SH. Evaluating the impact of trigeminal neuralgia. Pain. 2017;158(6):1166-1174.
Benoliel R, Gaul C. Persistent idiopathic facial pain. Cephalalgia. 2017;37(7):680-691.
May A. Facial pain is coming home. Cephalalgia. 2020;40(3):227-228.
Ziegeler C, Wasiljeff K, May A. Nondental orofacial pain in dental practices-diagnosis, therapy and self-assessment of German dentists and dental students. Eur J Pain. 2019;23(1):66-71.
Zakrzewska JM. Differential diagnosis of facial pain and guidelines for management. Br J Anaesth. 2013;111(1):95-104.
Mueller D, Obermann M, Yoon M-S, et al. Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: a population-based study. Cephalalgia. 2011;31(15):1542-1548.
Ziegeler C, Schulte LH, May A. Altered trigeminal pain processing on brainstem level in persistent idiopathic facial pain. Pain. 2020 Sep 18. Accessed October 27, 2020. https://journals.lww.com/pain/Abstract/9000/Altered_trigeminal_pain_processing_on_brainstem.98214.aspx
Bendtsen L, Zakrzewska JM, Heinskou TB, et al. Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia. Lancet Neurol. 2020;19(9):784-796.
The Orofacial Pain Classification Committee. International Classification of Orofacial Pain, 1st edition (ICOP). Cephalalgia. 2020;40(2):129-221.
Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition, ICHD-3. Cephalalgia. 2018;38(1):1-211.
Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition, ICHD-2. Cephalalgia. 2004;24(suppl 1):9-160.
Lance JW, Olesen J. The International Classification of Headache Disorders: 1st edition, ICHD-1. Cephalalgia. 1988;8(suppl 7):9-96.
Ziegeler C, Brauns G, Jürgens TP, May A. Shortcomings and missed potentials in the management of migraine patients-experiences from a specialized tertiary care center. J Headache Pain. 2019;20(1):86.
Ziegeler C, May A. Facial presentations of migraine, TACs, and other paroxysmal facial pain syndromes. Neurology. 2019;93(12):e1138.
Gräfe K, Zipfel S, Herzog W, Löwe B. Screening psychischer Störungen mit dem “Gesundheitsfragebogen für Patienten (PHQ-D)”. Diagnostica. 2004;50(4):171-181. https://doi.org/10.1026/0012-1924.50.4.171.
Koopman JSHA, Dieleman JP, Huygen FJ, de Mos M, Martin CGM, Sturkenboom MCJM. Incidence of facial pain in the general population. Pain. 2009;147(1-3):122-127.
Sommer C, Pfaffenrath V, May A, Türp JC, Engelter S, Wöber C. Anhaltender idiopathischer Gesichtsschmerz. Leitlinien Für Diagn Ther Neurol. Accessed March 9, 2018. https://www.dgn.org/leitlinien/2365-ll-53-2012-anhaltender-idiopathischer-gesichtsschmerz
Förderreuther S, Engelter S, Evers S, Paulus W, Tronnier V, Mitrovic N. Trigeminusneuralgie. Leitlinien Für Diagn Ther Neurol. Accessed November 6, 2018. https://www.dgn.org/leitlinien/2287-ll-58-2012-trigeminusneuralgie
Schlereth T. Diagnose und nicht interventionelle Therapie neuropathischer Schmerzen, S2k-Leitlinie. DGN - Dtsch Ges Für Neurol. Leitlinien für Diagnostik und Therapie in der. 2019 Sep 12. Accessed May 19, 2020. https://www.dgn.org/leitlinien/3805-ll-030-114-diagnose-und-nicht-interventionelle-therapie-neuropathischer-schmerzen-2019
Maarbjerg S, Wolfram F, Heinskou TB, et al. Persistent idiopathic facial pain-a prospective systematic study of clinical characteristics and neuroanatomical findings at 3.0 Tesla MRI. Cephalalgia. 2017;37(13):1231-1240.
Maarbjerg S, Di Stefano G, Bendtsen L, Cruccu G. Trigeminal neuralgia-diagnosis and treatment. Cephalalgia. 2017;37(7):648-657.
Forssell H, Tenovuo O, Silvoniemi P, Jääskeläinen SK. Differences and similarities between atypical facial pain and trigeminal neuropathic pain. Neurology. 2007;69(14):1451-1459.
Bendtsen L, Zakrzewska JM, Abbott J, et al. European Academy of Neurology guideline on trigeminal neuralgia. Eur J Neurol. 2019;26(6):831-849.
Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97(2):553-622.
Ziegeler C, May A. Facial paroxysmal hemicrania associated with the menstrual cycle. Cephalalgia Rep. 2019;1(2):2515816319857070.
Petzold GC, Dreier JP, Einhäupl KM, Arnold G. Cluster-like headache time-locked to the menstrual cycle. Neurology. 2003;60(6):1049.
Di Stefano G, Yuan J-H, Cruccu G, Waxman SG, Dib-Hajj SD, Truini A. Familial trigeminal neuralgia-a systematic clinical study with a genomic screen of the neuronal electrogenisome. Cephalalgia. 2020;40(8):767-777.
Panchagnula S, Sularz AK, Kahle KT. Familial trigeminal neuralgia cases implicate genetic factors in disease pathogenesis. JAMA Neurol. 2019;76(1):9-10.